InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Pasithea Therapeutics stock is falling on Wednesday after shares of KTTA underwent extreme volatility yesterday on study results.
The post Why Is Pasithea Therapeutics (KTTA) Stock Down 12% Today? appeared first on InvestorPlace.
More From InvestorPlace